BioSpace News Archive

Business

StrideBio Appoints Sapan Shah, Ph.D. as Chief Executive Officer

Experienced Biotech Executive to Lead Company’s Next Stage of Growth

January 3, 2019
·
3 min read
Genetown

Sojournix Completes $44 Million Series C Financing

Sojournix announced today the completion of a $44 million Series C financing.

January 3, 2019
·
5 min read
Deals

Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company

Highly Complementary Portfolios with Leading Franchises in Oncology, Immunology and Inflammation and Cardiovascular Disease

January 3, 2019
·
21 min read
Business

Nuvo Pharmaceuticals Announces Appointment of Rob Harris as Executive Chairman

Nuvo Pharmaceuticals Inc. today announced the appointment of Rob Harris as its Executive Chairman.

January 3, 2019
·
6 min read
Dompé announces first treatment with Oxervate™ eye drops (cenegermin-bkbj), for neurotrophic keratitis (NK)

Now available through Accredo, Oxervate is the first-in-class recombinant human nerve growth factor (rhNGF) and holds the potential to completely heal NK.

January 3, 2019
·
8 min read
Business

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel

Analytics 4 Life today announced that it has further strengthened its leadership team with the appointment of William Revelos as Vice President and General Counsel.

January 3, 2019
·
2 min read
Business

1ST Biotherapeutics and twoXAR Form Co-Development Collaboration to Discover and Develop Treatments for Glioblastoma

1ST Biotherapeutics, Inc. and twoXAR, Inc. today announced an agreement to jointly discover and develop novel, efficacious treatments to address unmet medical needs in glioblastoma multiforme (“glioblastoma”).

January 3, 2019
·
3 min read
Business

Rallybio Further Strengthens Leadership Team with Addition of Steven Ryder, MD, FACP

R&D Executive with Proven Track Record in the Biopharmaceutical Industry

January 3, 2019
·
3 min read
Biotech Beach

Forge Receives Second CARB-X Award For Up To $11.1M To Accelerate Development Of Novel Antibiotic To Treat Lung Infections

Forge Therapeutics, Inc. announced today that it has received a second CARB-X award for developing a novel antibacterial therapeutic agent.

January 3, 2019
·
5 min read
Business

PolarityTE to Report Fiscal Fourth Quarter Financial Results on January 14, 2019

PolarityTE, Inc. today announced that it will report its fiscal fourth quarter 2018 financial results by press release on January 14, 2019 at approximately 7:00 a.m. Eastern Time.

January 3, 2019
·
3 min read